JM

John Gary Montana

DL Darwin Discovery Limited: 39 patents #1 of 71Top 2%
CH Chiroscience: 12 patents #1 of 40Top 3%
Johnson & Johnson: 8 patents #1,241 of 7,810Top 20%
GL Glaxo Group Limited: 3 patents #340 of 1,368Top 25%
Genentech: 2 patents #1,171 of 2,392Top 50%
ZA Zafgen: 1 patents #12 of 15Top 80%
CS Chiesi Farmaceutici S.P.A.: 1 patents #189 of 341Top 60%
Overall (All Time): #27,920 of 4,157,543Top 1%
72
Patents All Time

Issued Patents All Time

Showing 1–25 of 72 patents

Patent #TitleCo-InventorsDate
10822342 Pyrazolopyrimidine derivatives as NIK inhibitors George Hynd, Patrizia Tisselli, Calum Macleod, Samuel Edward Mann, Terry Aaron Panchal +1 more 2020-11-03
10626089 Quinoline derivative in crystal form Donald John Daley, George Hynd, Mitsuru Teramoto, Takahiro Ito 2020-04-21
10323045 Thienopyrimidine derivatives as NIK inhibitors George Hynd, Patrizia Tisselli, Calum Macleod, Samuel Edward Mann, Stephen Price 2019-06-18
10221180 Pyrazolopyrimidine derivatives as NIK inhibitors George Hynd, Patrizia Tisselli, Calum Macleod, Samuel Edward Mann, Terry Aaron Panchal +1 more 2019-03-05
10005773 1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors George Hynd, Patrizia Tisselli, David Edward Clark, Janusz Jozef Kulagowski, Calum Macleod +3 more 2018-06-26
10005776 Compounds as NIK inhibitors George Hynd, Patrizia Tisselli, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann +1 more 2018-06-26
9981963 3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors George Hynd, Patrizia Tisselli, David Edward Clark, Janusz Jozef Kulagowski, Calum Macleod +3 more 2018-05-29
9981962 Pyrazole derivatives as NIK inhibitors George Hynd, Patrizia Tisselli, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann +2 more 2018-05-29
9643964 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer George Hynd, Stephen Price, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann +2 more 2017-05-09
9067905 Sulphone compounds and methods of making and using same Hazel Joan Dyke, Susan Mary Cramp, Thomas David Pallin, Janusz Kulagowski, Robert Zahler 2015-06-30
8669248 Adenine inhibitors of HSP90 Janusz Josef Kulagowski, Hazel Hunt, Yukari Y. PERRELLA 2014-03-11
8557797 Triazolopyridine derivatives and their therapeutic use Harry Finch, Monique Bodil Van Niel, Chi-Kit Woo, Jamie Knight, Bohdan Waszkowycz 2013-10-15
8394836 Indoles and their therapeutic use George Hynd, Harry Finch, Rosa Arienzo, Barbara Avitabile-Woo, Mathias Domostoj 2013-03-12
8394830 Quinolines and their therapeutic use Harry Finch, George Hynd, Michael Colin Cramp, Rosa Arienzo, Neville James McLean 2013-03-12
8173812 Quinolines and their therapeutic use Harry Finch, George Hynd, Michael Colin Cramp, Rosa Arienzo, Neville James McLean 2012-05-08
7893085 Aza-benzothiophenyl compounds and methods of use Pascal Pierre Alexandre Savy, Stephen Price, Hazel Joan Dyke, Karen Williams, Mark S. Stanley +1 more 2011-02-22
7858640 Quinolines and their therapeutic use Michael Colin Cramp, Rosa Arienzo, George Hynd, Peter Crackett, Yann Griffon +3 more 2010-12-28
7855216 Aza-indolyl compounds and methods of use Simon Charles Goodacre, Karen Williams, Stephen Price, Hazel Joan Dyke, Mark S. Stanley +2 more 2010-12-21
6818622 Selective MMP inhibitors having reduced side-effects John M. Bird, Ruth Elizabeth Wills, Andrew Douglas Baxter, David Alan Owen 2004-11-16
6680338 Hydroxamic and carboxylic acid derivatives Andrew Douglas Baxter, David Alan Owen, Robert J. Watson 2004-01-20
6642254 Heterocyclic compounds and their therapeutic use Hazel Joan Dyke 2003-11-04
6566384 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity David Alan Owen, John Keily, Robert J. Watson, Andrew Douglas Baxter 2003-05-20
6506764 Hydroxamic and carboxylic acid derivatives Andrew Douglas Baxter, David Alan Owen, Duncan Hannah 2003-01-14
6503910 Hydroxamic and carboxylic acid derivatives Andrew Douglas Baxter, David Alan Owen, Robert J. Watson 2003-01-07
6462042 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors David Alan Owen, Andrew Douglas Baxter, Robert J. Watson 2002-10-08